| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |